These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 2455447

  • 1. Effect of cyclosporine on the endocrine and exocrine pancreas in kidney transplant recipients.
    Yoshimura N, Nakai I, Ohmori Y, Aikawa I, Fukuda M, Yasumura T, Matsui S, Hamashima T, Oka T.
    Am J Kidney Dis; 1988 Jul; 12(1):11-7. PubMed ID: 2455447
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Posttransplant hyperglycemia. Increased incidence in cyclosporine-treated renal allograft recipients.
    Roth D, Milgrom M, Esquenazi V, Fuller L, Burke G, Miller J.
    Transplantation; 1989 Feb; 47(2):278-81. PubMed ID: 2645712
    [Abstract] [Full Text] [Related]

  • 4. Effects of cyclosporin A and low dosages of steroid on posttransplantation diabetes in kidney transplant recipients.
    Yamamoto H, Akazawa S, Yamaguchi Y, Yokota A, Yamasaki H, Nakanishi T, Tahara D, Matsuya F, Saito Y, Nagataki S.
    Diabetes Care; 1991 Oct; 14(10):867-70. PubMed ID: 1773683
    [Abstract] [Full Text] [Related]

  • 5. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
    Sutherland DE, Fryd DS, Strand MH, Canafax DM, Ascher NL, Payne WD, Simmons RL, Najarian JS.
    Am J Kidney Dis; 1985 Jun; 5(6):318-27. PubMed ID: 3893106
    [Abstract] [Full Text] [Related]

  • 6. Cyclosporine toxicity: the effect of combined therapy using cyclosporine, azathioprine, and prednisone.
    Lorber MI, Flechner SM, Van Buren CT, Sorensen K, Kerman RH, Kahan BD.
    Am J Kidney Dis; 1987 Jun; 9(6):476-84. PubMed ID: 3296744
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine.
    Rocher LL, Hodgson RJ, Merion RM, Swartz RD, Keavey S, Turcotte JG, Campbell DA.
    Transplantation; 1989 Feb; 47(2):249-54. PubMed ID: 2645707
    [Abstract] [Full Text] [Related]

  • 11. The impact of high lymphocyte sensitivity to glucocorticoids on kidney graft survival in patients treated with azathioprine and cyclosporine.
    Langhoff E, Ladefoged J.
    Transplantation; 1987 Mar; 43(3):380-4. PubMed ID: 3547794
    [Abstract] [Full Text] [Related]

  • 12. The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients.
    Boudreaux JP, McHugh L, Canafax DM, Ascher N, Sutherland DE, Payne W, Simmons RL, Najarian JS, Fryd DS.
    Transplantation; 1987 Sep; 44(3):376-81. PubMed ID: 3307061
    [Abstract] [Full Text] [Related]

  • 13. Experimental pancreatic allotransplantation in large animals. The role of donor kidney and cyclosporine in modifying rejection.
    Koyama I, Williams M, Cameron JL, Zuidema GD.
    Transplantation; 1986 Oct; 42(4):333-6. PubMed ID: 3094205
    [Abstract] [Full Text] [Related]

  • 14. A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years.
    Johnson CP, Simmons RL, Sutherland DE, Canafax DM, Ascher NL, Payne WD, Flick B, Najarian JS, Fryd DS.
    Transplantation; 1988 Feb; 45(2):380-5. PubMed ID: 3278431
    [Abstract] [Full Text] [Related]

  • 15. The impact of cytomegalovirus infection on seronegative recipients of seropositive donor kidneys versus seropositive recipients treated with cyclosporine-prednisone immunosuppression.
    Johnson PC, Lewis RM, Golden DL, Oefinger PE, Van Buren CT, Kerman RH, Kahan BD.
    Transplantation; 1988 Jan; 45(1):116-21. PubMed ID: 2827353
    [Abstract] [Full Text] [Related]

  • 16. The effect of cyclosporine on early graft function in human renal transplantation.
    Flechner SM, Payne WD, Van Buren C, Kerman R, Kahan BD.
    Transplantation; 1983 Sep; 36(3):268-72. PubMed ID: 6351368
    [Abstract] [Full Text] [Related]

  • 17. Effective long-term immunosuppression maintained by low cyclosporine levels in primary cadaveric renal transplant recipients.
    Kupin WL, Venkat KK, Norris C, Florence-Green D, Dienst S, Oh HK, Feldkamp C, Levin NW.
    Transplantation; 1987 Feb; 43(2):214-8. PubMed ID: 3544378
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Low-dose cyclosporine for cadaveric renal transplantation.
    Vanderwerf BA, Serota AI.
    Transplantation; 1988 Feb; 45(2):320-3. PubMed ID: 3278422
    [Abstract] [Full Text] [Related]

  • 20. Long-term results with cyclosporine monotherapy in renal transplant patients: a multivariate analysis of risk factors.
    Montagnino G, Tarantino A, Maccario M, Elli A, Cesana B, Ponticelli C.
    Am J Kidney Dis; 2000 Jun; 35(6):1135-43. PubMed ID: 10845828
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.